Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation

被引:28
作者
Bruun, L [1 ]
Ekberg, H
Bjork, T
Lilja, H
Höglund, P
Christensson, A
机构
[1] Lund Univ, Univ Hosp UMAS, Dept Nephrol & Transplantat, SE-20502 Malmo, Sweden
[2] Lund Univ, Univ Hosp UMAS, Dept Urol, SE-20502 Malmo, Sweden
[3] Lund Univ, Univ Hosp UMAS, Dept Clin Chem, SE-20502 Malmo, Sweden
[4] Lund Univ Hosp, Dept Clin Pharmacol, Malmo, Sweden
[5] Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
kidney transplantation; kidney; prostate-specific antigen; tissue kallikreins; kidney glomerulus;
D O I
10.1097/01.ju.0000118580.19344.68
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The low molecular mass and short half-life of free (f) prostate specific antigen (PSA) implies elimination from blood by glomerular filtration. In addition, patients with terminal renal failure have increased fPSA in serum but there have been sparse data reported on the rates and pathways of elimination of PSA complexes and human kallikrein 2 (hK2). We studied glomerular filtration dependent elimination of fPSA and hK2 in patients with renal insufficiency undergoing successful renal transplantation. Materials and Methods: We studied 14 patients with immediate onset of renal function after renal transplantation. Blood samples were obtained before and at regular intervals up to 160 hours after transplanted kidney reperfusion. Measurements of fPSA, total PSA and hK2 were performed with immunofluorometric assays and complexed PSA was determined by a chemiluminiscence assay. Glomerular filtration rates were monitored by analyzing serum creatinine and cystatin C. NONMEM, a multivariate pharmacokinetic approach, was used to determine the elimination rates of fPSA and hK2 after renal transplantation. Results: Serum fPSA and hK2 but not PSA complexes, decreased rapidly after renal transplantation. Significant reductions in fPSA and hK2 were observed after only 16 and 8 hours, respectively. fPSA and hK2 showed similar elimination patterns, decreasing to 42% and 44% of their original levels compared to cystatin C, which was at 44% after 160 hours. The median half-lives of fPSA and hK2 were 17.4 and 11.5 hours, respectively. Conclusions: These results verify the hypothesis that fPSA and hK2 are eliminated from the blood circulation by glomerular filtration and severe renal failure influences the levels of the 2 proteins in serum.
引用
收藏
页码:1432 / 1435
页数:4
相关论文
共 20 条
[1]  
BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195
[2]   Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (hK2) in serum [J].
Becker, C ;
Piironen, T ;
Pettersson, K ;
Björk, T ;
Wojno, KJ ;
Oesterling, JE ;
Lilja, H .
JOURNAL OF UROLOGY, 2000, 163 (01) :311-316
[3]  
Becker C, 2000, CLIN CHEM, V46, P198
[4]   Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha1-antichymotrypsin from serum [J].
Björk, T ;
Ljungberg, B ;
Piironen, T ;
Abrahamsson, PA ;
Pettersson, K ;
Cockett, ATK ;
Lilja, H .
UROLOGY, 1998, 51 (01) :57-62
[5]   Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy -: A critical assessment [J].
Brändle, E ;
Hautmann, O ;
Bachem, M ;
Kleinschmidt, K ;
Gottfried, HW ;
Grünert, A ;
Hautmann, RE .
UROLOGY, 1999, 53 (04) :722-730
[6]   Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment [J].
Bruun, L ;
Björk, T ;
Lilja, H ;
Becker, C ;
Gustafsson, O ;
Christensson, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) :598-602
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ration in clinical practice [J].
Collins, GN ;
Martin, PJ ;
WynnDavies, A ;
Brooman, PJ ;
OReilly, PH .
JOURNAL OF UROLOGY, 1997, 157 (05) :1744-1747
[9]   Cystatin C - Properties and use as diagnostic marker [J].
Grubb, AO .
ADVANCES IN CLINICAL CHEMISTRY, VOL 35, 2001, 35 :63-99
[10]   CHARGE SELECTIVITY OF THE GLOMERULAR-FILTRATION BARRIER IN HEALTHY AND NEPHROTIC HUMANS [J].
GUASCH, A ;
DEEN, WM ;
MYERS, BD .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2274-2282